本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immunocore Holdings plc

29.04
-0.3500-1.19%
盘后:29.040.00000.00%19:30 EDT
成交量:21.97万
成交额:641.37万
市值:14.96亿
市盈率:-81.44
高:29.73
开:29.48
低:29.02
收:29.39
52周最高:40.71
52周最低:27.56
股本:5,149.86万
流通股本:4,583.49万
量比:0.50
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.3566
每股收益(LYR):-0.7054
净资产收益率:-4.47%
总资产收益率:-0.16%
市净率:3.56
市盈率(LYR):-41.17

数据加载中...

2022/07/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence